Researchers found that high brain metabolism is associated with longer overall survival, and it's an independent prognostic factor for overall survival. Brain metabolism measured by ¹⁸F-FDG PET/CT provides valuable insight into patient outcomes and may help identify patients most likely to benefit from early supportive care.
SourceSociety of Nuclear Medicine and Molecular Imaging·JournalJournal of Nuclear Medicine·DateJul 24, 2026
The NRG Oncology trial showed a sustained overall survival benefit for patients with advanced or recurrent endometrial cancer treated with pembrolizumab and chemotherapy, even after post-study immunotherapy. The benefit persisted in both mismatch repair proficient and deficient populations.
A nighttime response during out-of-hospital cardiac arrest is associated with lower odds of sustained return of spontaneous circulation, neurologically favorable survival, and postresuscitation survival. Emergency care factors only account for a portion of the decreased survival rates at night.
SourceJAMA Network·JournalJAMA Network Open·DateApr 29, 2026
A new method called scSurvival uses single-cell genetic data to identify which cells inside a tumor are most strongly linked to patient survival. The approach pinpoints harmful and helpful cell populations that can drive disease progression, enabling better understanding of why patients with the same cancer have different outcomes.
SourceOregon Health & Science University·JournalCancer Discovery·DateApr 21, 2026
Apple iPhone 17 Pro
Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.
A global, multicentre phase III trial demonstrates the potential of Dato-DXd as an effective new treatment option for triple-negative breast cancer. The novel antibody-drug conjugate (ADC) nearly doubles overall survival and improves progression-free survival in patients with untreated, advanced TNBC.
SourceSingHealth·JournalAnnals of Oncology·TypeRandomized controlled/clinical trial·DateApr 16, 2026
The study found that immune checkpoint inhibitors significantly improved key clinical outcomes, including disease-free survival and distant metastasis-free survival. However, no clear improvement in overall survival was observed across studies, highlighting the need for careful patient selection and monitoring.
SourceImpact Journals LLC·JournalOncotarget·TypeNews article·DateApr 7, 2026
A study of over 2,300 North Carolina women with ovarian cancer found that both quick and delayed diagnoses had worse survival rates than those diagnosed in the middle. Considering patient severity may improve outcomes for some symptomatic patients.
SourceUNC Gillings School of Global Public Health·JournalJAMA Network Open·DateMar 27, 2026
The NRG-LU005 trial found that immunotherapy atezolizumab did not improve survival for patients with limited-stage small cell lung cancer when added to chemoradiation. Twice-daily radiation therapy, however, was associated with improved survival in this population.
SourceAlliance for Clinical Trials in Oncology·JournalJournal of Clinical Oncology·TypeRandomized controlled/clinical trial·DateMar 12, 2026
Fluke 87V Industrial Digital Multimeter
Fluke 87V Industrial Digital Multimeter is a trusted meter for precise measurements during instrument integration, repairs, and field diagnostics.
A new study found that commonly prescribed cardiovascular medications, such as statins and diuretics, do not worsen survival in multiple myeloma patients. The research suggests that these medications can often be continued without clear evidence of harming survival outcomes.
SourceUniversity of Sharjah·TypeMeta-analysis·DateMar 1, 2026
A new UCLA study suggests that adding hormone therapy to post-operative radiotherapy may provide little survival benefit for most men with prostate cancer, especially those with low PSA levels. However, men with higher PSA levels before radiation may see modest improvements in survival and metastasis-free survival.
SourceUniversity of California - Los Angeles Health Sciences·JournalThe Lancet·DateFeb 26, 2026
Women with stage IV breast cancer detected through screening have a 60% chance of survival ten years after diagnosis, compared to under 20% without screening. Screening may not be too late to treat successfully, even at the most serious stage of the disease.
SourceKing's College London·JournalJNCI Journal of the National Cancer Institute·DateFeb 18, 2026
A major study has shown that tumour stage at diagnosis is strongly linked to childhood cancer survival across six different cancers. Researchers analysed data from 9,883 children in 27 countries and found significant variation in three-year survival rates between regions, particularly in the UK and Ireland.
SourceUniversity College London·JournalJAMA Network Open·TypeMeta-analysis·DateFeb 9, 2026
Research finds that reducing wolves improves caribou calf survival in mountainous regions due to the inability of bears and wolverines to catch older calves. In contrast, flatter landscapes with accessible trails see no improvement in survival rates as other predators fill the gap.
SourceUniversity of British Columbia·JournalThe Journal of Wildlife Management·TypeObservational study·DateFeb 5, 2026
Meta Quest 3 512GB
Meta Quest 3 512GB enables immersive mission planning, terrain rehearsal, and interactive STEM demos with high-resolution mixed-reality experiences.
A study analyzing 3225 trauma patients in South East England found that air ambulance pre-hospital care significantly improved survival rates, with 2125 patients exceeding 30-day survival. Those most likely to benefit were severely injured patients with moderate probability of survival, who unexpectedly survived for 30 days.
SourceBMJ Group·JournalEmergency Medicine Journal·TypeData/statistical analysis·DateFeb 3, 2026
A new study of over 32,000 US Veterans found that longer treatment with medications for opioid use disorder is associated with a greater probability of short- and medium-term survival. The benefit continues to increase at least for four years of ongoing treatment.
SourceSociety for the Study of Addiction·JournalAddiction·TypeObservational study·DateJan 8, 2026
A major international study reveals significant disparities in childhood cancer survival rates worldwide. The global average is just 37% survival rate, while high-income countries boast an 80% rate. Better monitoring and investment in healthcare are critical to achieve the WHO's goal of at least 60% survival by 2030.
SourceThe University of Bergen·JournalJNCI Journal of the National Cancer Institute·DateDec 15, 2025
A new study identifies a practical and powerful prognostic marker that can help clinicians tailor treatment strategies to improve survival for patients with aggressive T-cell lymphoma. Researchers found that patients who relapse within 12 months of initial therapy have a dramatically declining chance of survival, making targeted therap...
SourceMassachusetts Institute of Technology·DateDec 8, 2025
A study of over 60,000 US patients with advanced breast cancer found average survival times increased by six to seven months since 2011. Researchers attribute the improvement to more effective treatments, wider diagnosis, and quality of care advancements.
SourceAssociação Advanced Breast Cancer Global Alliance·TypeObservational study·DateNov 5, 2025
GQ GMC-500Plus Geiger Counter
GQ GMC-500Plus Geiger Counter logs beta, gamma, and X-ray levels for environmental monitoring, training labs, and safety demonstrations.
A study of 12,490 dementia cases found significant variations in survival times among early onset dementia patients by clinical subtype. The study revealed that those with frontotemporal dementia or Lewy body dementia had the shortest survival time, while Alzheimer's disease and vascular cognitive impairment had longer average survival...
SourceBMJ Group·JournalJournal of Neurology Neurosurgery & Psychiatry·TypeObservational study·DateNov 4, 2025
The phase 3 FLAURA2 study shows that adding platinum-pemetrexed to osimertinib improves overall survival in patients with newly diagnosed EGFR-mutated advanced NSCLC. Median overall survival was 47.5 months, compared to 37.6 months with osimertinib alone.
SourceDana-Farber Cancer Institute·JournalNew England Journal of Medicine·DateOct 17, 2025
The proton therapy cohort of NRG-BN001 demonstrated improved overall survival (OS) for patients with newly diagnosed glioblastoma, with a 6.8% absolute survival advantage at 2 years. The results support the development of a phase III randomized trial to confirm these findings.
The FLAURA2 trial shows osimertinib plus chemotherapy significantly improves overall survival compared to osimertinib monotherapy in patients with EGFR-mutated advanced NSCLC. The combination also demonstrates a manageable safety profile, extending survival for these patients.
SourceInternational Association for the Study of Lung Cancer·DateSep 7, 2025
SAMSUNG T9 Portable SSD 2TB
SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.
A retrospective cohort study found that adjuvant chemotherapy improves survival in resected early-onset pancreatic cancer patients after neoadjuvant therapy. EOPC patients showed superior survival compared to average-onset pancreatic cancer, with ACT further enhancing outcomes.
SourceXia & He Publishing Inc.·JournalOncology Advances·DateAug 7, 2025
A long-term study in southeastern Madagascar found that protected forest fragments improve the survival of endangered mouse lemurs. The study suggests that habitat protection is critical for conserving this species.
SourceNorwegian University of Life Sciences·JournalOikos·TypeData/statistical analysis·DateAug 5, 2025
A European study analyzed data from over 30,000 children with brain tumors, providing a clear overview of their survival outcomes. The study found that differences in survival rates between countries are smaller than previously thought, suggesting improved access to similar treatments across Europe.
SourcePrincess Máxima Center for Pediatric Oncology·JournalThe Lancet Oncology·TypeData/statistical analysis·DateJul 28, 2025
A major international study found that deceased-donor kidney transplantation offers a consistent survival advantage with standard-criteria kidneys, but the benefit plateaus in older and high-risk recipients. The study used a robust target trial emulation framework to compare long-term survival between transplant patients and those on d...
A new study found that surgical ablation during coronary artery bypass grafting (CABG) is associated with a risk-adjusted median survival advantage of 4.4 months compared to those who did not receive ablation. Patients treated by surgeons who frequently performed the procedure had an even greater median survival advantage.
SourceThe Society of Thoracic Surgeons·JournalThe Annals of Thoracic Surgery·DateJun 4, 2025
Nikon Monarch 5 8x42 Binoculars
Nikon Monarch 5 8x42 Binoculars deliver bright, sharp views for wildlife surveys, eclipse chases, and quick star-field scans at dark sites.
Scientists developed an AI method using ensemble techniques to predict overall survival rate of prostate cancer patients. Gradient Boosting performed exceptionally well, achieving a perfect score in accuracy and precision.
SourceUniversity of Sharjah·JournalComputers in Biology and Medicine·TypeComputational simulation/modeling·DateJun 2, 2025
A Dana-Farber study found that patients with stage III colon cancer who consumed an anti-inflammatory diet had longer overall survival post-treatment compared to those on a proinflammatory diet. Engaging in higher levels of physical activity also amplified the positive influence on survival.
A Phase III trial led by MD Anderson Cancer Center demonstrates a triplet combination of encorafenib, cetuximab and mFOLFOX6 significantly improves progression-free survival and overall survival in BRAF V600E-mutated metastatic colorectal cancer. The regimen offers a clear survival advantage over standard chemotherapy alone.
SourceUniversity of Texas M. D. Anderson Cancer Center·DateMay 30, 2025
A new study finds that radioiodine therapy significantly increases relative survival rates in differentiated thyroid cancer patients, with benefits observed across low-, intermediate-, and high-risk subgroups. The treatment reduces recurrence rates and improves long-term survival in high-risk groups, while also showing promise for low-...
SourceSociety of Nuclear Medicine and Molecular Imaging·JournalJournal of Nuclear Medicine·DateApr 25, 2025
Researchers used AI-driven methods to analyze thousands of digital images of melanoma tumor tissue, identifying key immune cell structures that boost immunotherapy effects. The presence of these structures was linked to significantly better overall survival for patients with advanced melanoma.
Anker Laptop Power Bank 25,000mAh (Triple 100W USB-C)
Anker Laptop Power Bank 25,000mAh (Triple 100W USB-C) keeps Macs, tablets, and meters powered during extended observing runs and remote surveys.
A new study found that survival rates for athletes suffering sudden cardiac arrest vary significantly by race, with 57% of Black athletes and 54% of other race athletes dying between 2014-2023. Improved emergency preparedness likely played a role in increased survival rates.
SourceAmerican College of Cardiology·JournalJournal of the American College of Cardiology·DateMar 30, 2025
A study published in the British Journal of General Practice found a significant link between chest x-ray referrals and earlier lung cancer diagnosis and better survival rates. Patients attending practices with high chest x-ray usage were more likely to be diagnosed at an earlier stage, leading to improved survival rates.
SourceUniversity of Sheffield·JournalBritish Journal of General Practice·TypeObservational study·DateMar 24, 2025
Increased visceral adipose tissue density and decreased skeletal muscle area are predictors of post-esophagectomy pulmonary complications. Decreased skeletal muscle density is associated with poorer overall survival. Routine morphomic analysis can help identify patients at risk and tailor perioperative care.
SourceNational Center for Respiratory Medicine·JournalJournal of Thoracic Disease·TypeObservational study·DateFeb 25, 2025
A new study published in the European Journal of Cardio-Thoracic Surgery found that mechanical heart valve replacements have better long-term survival rates compared to biological valves. Patients who received mechanical valves had improved survival up to 13 years after surgery, with smaller valves showing greater benefits.
SourceUniversity of Bristol·JournalEuropean Journal of Cardio-Thoracic Surgery·TypeObservational study·DateFeb 11, 2025
Apple AirPods Pro (2nd Generation, USB-C)
Apple AirPods Pro (2nd Generation, USB-C) provide clear calls and strong noise reduction for interviews, conferences, and noisy field environments.
Research presented at the 2025 STS Annual Meeting reveals that anatomic lung resections such as lobectomy and segmentectomy are associated with improved long-term survival compared to wedge resection for stage 1A NSCLC. Lobectomy offered the highest survival rates, with a 71.9% 5-year OS and 44.8% 10-year OS.
A study analyzing over a million Medicare patients found that those receiving multi-arterial grafts had improved survival compared to single-arterial graft recipients. However, when accounting for unmeasured confounding variables using surgeon preference as an instrumental variable, no difference in long-term survival was observed.
A phase III trial found that combining radiotherapy with cetuximab improved disease-free survival in patients with HPV-negative head and neck cancer, but not overall survival. The treatment was also associated with higher rates of acute toxicity.
SourceNRG Oncology·JournalJournal of Clinical Oncology·DateJan 24, 2025
A recent study found that cancer patients who traveled to local or national healthcare centers had higher five-year survival rates compared to those who remained in their residential cities. The study highlights critical disparities in healthcare resource allocation and quality across regions.
SourceHealth Data Science·JournalHealth Data Science·DateJan 8, 2025
A randomized phase 2 clinical trial shows that adding high-dose, intravenous vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer from eight months to 16 months. Patients also experience improved quality of life with reduced side effects.
SourceUniversity of Iowa Health Care·JournalRedox Biology·TypeRandomized controlled/clinical trial·DateNov 18, 2024
Sky-Watcher EQ6-R Pro Equatorial Mount
Sky-Watcher EQ6-R Pro Equatorial Mount provides precise tracking capacity for deep-sky imaging rigs during long astrophotography sessions.
A new study from Japan confirms that definitive criteria for lower cachexia prevalence rates are linked to reduced survival rates in cancer patients. The study found that the diagnostic criteria used for cachexia detection can affect reported prevalence and survival outcomes, emphasizing the need for accurate diagnosis.
SourceShinshu University·JournalAdvances in Nutrition·TypeMeta-analysis·DateNov 6, 2024
The German wolf population boasts the world's highest survival rates of wolves, with young wolves reaching 75% annual survival probability. The expansion is attributed to suitable habitats and protection, leading to a median survival time of three years.
SourceLeibniz Institute for Zoo and Wildlife Research (IZW)·JournalWildlife Biology·TypeData/statistical analysis·DateOct 31, 2024
A clinical trial shows promise in using a gene signature to tailor chemotherapy for high-risk breast cancer patients, improving disease-free survival rates. Patients classified as low risk had significantly higher rates of disease-free and overall survival compared to those at high risk.
SourceBMJ Group·JournalThe BMJ·TypeCommentary/editorial·DateOct 23, 2024
Researchers found that multi-source data linkage enhances reliability of population-based cancer survival estimates in a metropolitan Chinese cancer registry. The study's findings have significant public health implications for optimizing cancer patient follow-up strategies in China and other developing countries.
SourceHigher Education Press·JournalMalignancy Spectrum·TypeExperimental study·DateOct 12, 2024
Apple MacBook Pro 14-inch (M4 Pro)
Apple MacBook Pro 14-inch (M4 Pro) powers local ML workloads, large datasets, and multi-display analysis for field and lab teams.
A recent analysis reveals that the Dependent Coverage Expansion (DCE) provision of the Affordable Care Act has improved the survival rates and reduced the death rates of young adults diagnosed with cancer. The study found a significant improvement in both cancer survival and death rate trends after ACA implementation, particularly for ...
A new trial suggests that adding immunotherapy to chemoradiation can extend survival in patients with limited-stage small cell lung cancer. However, the findings also indicate that delivering the treatments at different times yields varying results, with concurrent treatment not offering improved survival benefits.
SourceAmerican Society for Radiation Oncology·DateSep 30, 2024
The study analyzes 40 years of avalanche data, showing a significant increase in survival rates from 43.5% to 53.5% and a decrease in rescue time from 45 minutes to 25 minutes.
SourceEurac Research·JournalJAMA·TypeLiterature review·DateSep 26, 2024
A NIH-supported study found that Black adults and women had fewer gains in survival rates compared to white adults and men receiving bystander CPR. Average survival benefits were three times higher for white adults and twice as high for men compared to women.
SourceNIH/National Heart, Lung and Blood Institute·JournalCirculation·DateAug 7, 2024
A recent study published in CANCER found that patients with metastatic non–small cell lung cancer treated with immunotherapy had improved overall and cancer-specific survival rates compared to those without it. The median overall survival was eight months, while cancer-specific survival was 10 months.
Rigol DP832 Triple-Output Bench Power Supply
Rigol DP832 Triple-Output Bench Power Supply powers sensors, microcontrollers, and test circuits with programmable rails and stable outputs.
Researchers found that patterns of neural activity in the hypothalamus predict performance in survival tasks, while associations with other brain regions were observed for hunting and escaping behaviors. The study provides new insights into how the human brain coordinates survival strategies.
SourcePLOS·JournalPLOS Biology·TypeComputational simulation/modeling·DateJun 27, 2024
A study by UCLA Health Jonsson Comprehensive Cancer Center researchers found that combining experimental immunotherapy drugs with chemotherapy significantly improves progression-free survival and overall survival for patients with metastatic colorectal cancer. The median progression-free survival was 6.2 months compared to 2.1 months f...
SourceUniversity of California - Los Angeles Health Sciences·DateMay 24, 2024
A new study found that survival rates after hip or spine fractures are comparable to or worse than those seen in patients with certain types of cancer. The study, which analyzed data from over 100,000 Canadians aged 65 and older, highlights the urgent need for secondary prevention interventions before hospital discharge.
SourceOxford University Press USA·JournalJBMR Plus·TypeContent analysis·DateApr 9, 2024
A new treatment combining a novel drug with traditional chemotherapy has been shown to increase the survival of patients with malignant mesothelioma, a rare and aggressive cancer. The ATOMIC-meso trial found that this treatment quadrupled the survival at 36 months compared to placebo-chemotherapy.
SourceQueen Mary University of London·JournalJAMA Oncology·TypeRandomized controlled/clinical trial·DateFeb 15, 2024
A new study from Boston University School of Medicine found that early whole blood transfusions improve survival in severely bleeding trauma patients. The researchers analyzed 1,394 patients and found that the earlier the patient received whole blood transfusion, the greater the chance of survival.
SourceBoston University School of Medicine·JournalJAMA Surgery·TypeData/statistical analysis·DateJan 31, 2024
AmScope B120C-5M Compound Microscope
AmScope B120C-5M Compound Microscope supports teaching labs and QA checks with LED illumination, mechanical stage, and included 5MP camera.
A new study has overturned conventional wisdom on wild turkey nesting survival, revealing that precipitation levels during nesting season are not related to reproductive success. The researchers found that temperatures above historical averages were associated with higher rates of daily nest survival during incubation.
SourceNorth Carolina State University·JournalJournal of Wildlife Management·TypeObservational study·DateDec 13, 2023
A new therapy, venetoclax, has improved survival rates for Non-Hispanic Black patients with acute myeloid leukemia, narrowing the racial disparity. The study analyzed over 3,000 adult patients diagnosed between 2014 and 2022 and found a significant increase in two-year overall survival rates.
SourceUniversity of Pennsylvania School of Medicine·DateDec 11, 2023
Researchers have discovered a promising new treatment option for pancreatic cancer, using polyinosine-polycytidylic acid (pIC) delivered directly into tumor cells. The approach suppresses tumor growth, induces cancer cell death, and enhances survival in animal models with the most common form of pancreatic cancer.
SourceVirginia Commonwealth University·JournalJournal for ImmunoTherapy of Cancer·DateNov 10, 2023
A large-scale study found that low-dose CT screening increases the 20-year survival rate of lung cancer patients from 18.6% to 81%, with Stage I cancers having an even higher long-term survival rate of 95%. Early detection through annual screening can effectively cure lung cancer in the long term.
SourceRadiological Society of North America·JournalRadiology·DateNov 7, 2023
Sky & Telescope Pocket Sky Atlas, 2nd Edition
Sky & Telescope Pocket Sky Atlas, 2nd Edition is a durable star atlas for planning sessions, identifying targets, and teaching celestial navigation.
A new AI-based tool estimates patient-specific cancer survival rates using machine learning, offering personalized prognosis for patients with breast, thyroid, and pancreatic cancers. The Cancer Survival Calculator differs from existing estimators by incorporating multiple factors beyond disease stage.
SourceAmerican College of Surgeons·TypeData/statistical analysis·DateOct 20, 2023